The CDC announced on Thursday a recommendation that a different class of antibiotics, cephalosporins, be used in its place.
"Gonorrhea has now joined the list of other superbugs for which treatment options have become dangerously few," said Dr. Henry Masur, president of the Infectious Disease Society of America. "To make a bad problem even worse, we're also seeing a decline in the development of new antibiotics to treat these infections."
The CDC made their recommendation after finding out that nearly seven percent of gonorrhea cases among heterosexual men from a survey of 26 U.S. cities last year had strains of the STD that were resistant to the drugs. The amount of cases in 2001 that were resistant to the drug among heterosexual men was only 0.6 percent, which points to a drastic rise.
"That leaves us with a single class of highly effective antibiotics," said Dr. John Douglas Jr., director of the CDC's division of STD prevention.
Other experts also called the situation very serious.
The CDS's recommendation is the first time that cephalosporins have been recommended to treat gonorrhea for the entire U.S. The CDC did, however, recommend that the antibiotics be used to treat drug resistant gonorrhea in California and Hawaii in 2002. The CDC also made the same recommendation to treat the CDC two years later for homosexual men.
The newly recommended antibiotics do include the generic drug ceftriaxone, known under the brand name Rocephin. This must be injected and "works very well" although the drug is not commonly stocked in doctor's offices.
This is in contrast to drugs such as Cipro and other fluoroquinolones were are commonly available and easy to use because they can take orally in one dose.
Ceftriaxone on the other hand must be given as a shot for $20, although the cost is about the same as Cipro, according to Atlanta pharmacist Ira Katz.
The CDC estimates that over 700,000 people in the U.S. get gonorrhea yearly through sexual contact.
Sources:
http://www.mlive.com/newsflash/health/index.ssf?/base/national-8/117639600479160.xml&storylist=health
http://www.reuters.com/article/healthNews/idUSHO26790120070412
Published by Jack McGoughey
Based in Texas, Jack McGoughey has been writing professionally for over a decade. His articles have appeared in several magazines and websites. View profile
- Drug Store Wars: Walgreens, CVS Move In. Is Wal-Mart Really a Problem? After CVS acquired some 700 Sav-on drug stores this past summer, more rivals such as Walgreens and Rite Aid have appeared. For all the bad publicity Wal-Mart receives, is the company really "taking over"?
-
Progesterex: A New Date Rape Drug?
There have been a lot of e-mails circulating this week of a new buzz word âprogesterex'. The word on the cyber street is that it is a new drug that is used in c...
- New Breast Cancer Drug Given FDA Approval GlaxoSmithKline was given FDA approval on Tuesday for a new breast cancer fighting drug. The company says it is nearly twice as effective as the current treatment alone at delaying the development of aggressive tumors.
- Prepare your Toddler for the New Baby Your first-born child has been the center of your life for his or her entire life, so it is no wonder that you are going to need to prepare your toddler for the arrival of a new baby brother or sister. In order to ma...
- The CIA and Their Drug Smuggling History A short article highlighting the connection between the Central Intelligence Agency and their wheelings and dealings with major drug trafficers.
- How to Use the Drug Facts Chart on Over-the-Counter Medications
- Drug Treatment Centers: Helping You Help Yourself Return to Sobriety
- The Best OTC Drug for Canker Sores
- Signs and Symptoms of a Drug Addiction
- Drug And/or Alcohol Rehabilitation Centers in Canton, Ohio
- Drug Expiration Dates: How They Benefit the Pharmaceutical Companies
- The Truth About Ritalin: Dangerous Drug for ADHD
|
|